Leszek B Kiliman
Examiner (ID: 1930, Phone: (571)272-1509 , Office: P/1788 )
Most Active Art Unit | 1773 |
Art Unit(s) | 1788, 1787, 1509, 1316, 1773, 1794 |
Total Applications | 2689 |
Issued Applications | 2219 |
Pending Applications | 93 |
Abandoned Applications | 377 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 15990049
[patent_doc_number] => 20200170895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => POLYUREA CAPSULE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/780158
[patent_app_country] => US
[patent_app_date] => 2020-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16780158
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/780158 | POLYUREA CAPSULE COMPOSITIONS | Feb 2, 2020 | Pending |
Array
(
[id] => 18619119
[patent_doc_number] => 11752141
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis
[patent_app_type] => utility
[patent_app_number] => 16/752590
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12161
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16752590
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/752590 | Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis | Jan 23, 2020 | Issued |
Array
(
[id] => 17480744
[patent_doc_number] => 20220088248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => IMPROVED METHOD AND COMPOSITIONS FOR SURFACE TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/422157
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/422157 | IMPROVED METHOD AND COMPOSITIONS FOR SURFACE TREATMENT | Jan 9, 2020 | Pending |
Array
(
[id] => 16673020
[patent_doc_number] => 20210061783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => Synthetic Nicotine Composition
[patent_app_type] => utility
[patent_app_number] => 16/734413
[patent_app_country] => US
[patent_app_date] => 2020-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1648
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16734413
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/734413 | Synthetic nicotine composition | Jan 5, 2020 | Issued |
Array
(
[id] => 17472479
[patent_doc_number] => 20220079983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => NANOPARTICLES AND PREPARATION METHOD
[patent_app_type] => utility
[patent_app_number] => 17/420507
[patent_app_country] => US
[patent_app_date] => 2020-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3430
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420507
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/420507 | NANOPARTICLES AND PREPARATION METHOD | Jan 1, 2020 | Pending |
Array
(
[id] => 17426678
[patent_doc_number] => 20220054386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/414663
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17414663
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/414663 | COMPOSITION | Dec 19, 2019 | Pending |
Array
(
[id] => 15797139
[patent_doc_number] => 20200121712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => AGENT TO BE APPLIED TO OPHTHALMIC DEVICE
[patent_app_type] => utility
[patent_app_number] => 16/720909
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16720909
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/720909 | AGENT TO BE APPLIED TO OPHTHALMIC DEVICE | Dec 18, 2019 | Abandoned |
Array
(
[id] => 17458561
[patent_doc_number] => 20220071865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => MICROCAPSULES PREPARED FROM PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/416096
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416096
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416096 | MICROCAPSULES PREPARED FROM PROTEINS | Dec 16, 2019 | Pending |
Array
(
[id] => 17458558
[patent_doc_number] => 20220071862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => MICROCAPSULE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/416084
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416084
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416084 | MICROCAPSULE COMPOSITIONS | Dec 16, 2019 | Pending |
Array
(
[id] => 17458560
[patent_doc_number] => 20220071864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => HYDROXYETHYL CELLULOSE MICROCAPSULES
[patent_app_type] => utility
[patent_app_number] => 17/416090
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16960
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416090
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416090 | HYDROXYETHYL CELLULOSE MICROCAPSULES | Dec 16, 2019 | Pending |
Array
(
[id] => 17398568
[patent_doc_number] => 20220040658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => GUAR GUM MICROCAPSULES
[patent_app_type] => utility
[patent_app_number] => 17/416080
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17436
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416080
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416080 | GUAR GUM MICROCAPSULES | Dec 16, 2019 | Pending |
Array
(
[id] => 19338584
[patent_doc_number] => 12048755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-30
[patent_title] => Microcapsule compositions prepared from polysaccharides
[patent_app_type] => utility
[patent_app_number] => 17/416085
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22641
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416085
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416085 | Microcapsule compositions prepared from polysaccharides | Dec 16, 2019 | Issued |
Array
(
[id] => 17790934
[patent_doc_number] => 20220250025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => PROTEIN MICROCAPSULES AND METHOD OF PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/416099
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15436
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416099
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416099 | PROTEIN MICROCAPSULES AND METHOD OF PREPARING THE SAME | Dec 16, 2019 | Pending |
Array
(
[id] => 16883836
[patent_doc_number] => 20210170031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => ORAL COMPOSITION WITH NANOCRYSTALLINE CELLULOSE
[patent_app_type] => utility
[patent_app_number] => 16/707164
[patent_app_country] => US
[patent_app_date] => 2019-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16707164
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/707164 | ORAL COMPOSITION WITH NANOCRYSTALLINE CELLULOSE | Dec 8, 2019 | Pending |
Array
(
[id] => 15738383
[patent_doc_number] => 20200108079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => Serum Cholesterol Lowering Edible Product
[patent_app_type] => utility
[patent_app_number] => 16/705287
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16705287
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/705287 | Serum Cholesterol Lowering Edible Product | Dec 5, 2019 | Abandoned |
Array
(
[id] => 15738259
[patent_doc_number] => 20200108017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => TWO SPEED MONOLITHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS
[patent_app_type] => utility
[patent_app_number] => 16/704829
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16704829
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/704829 | TWO SPEED MONOLITHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS | Dec 4, 2019 | Abandoned |
Array
(
[id] => 17460453
[patent_doc_number] => 20220073758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => PROCESS FOR PREPARING A SURFACE WITH BACTERIOSTATIC ACTIVITY AND SURFACE THUS PREPARED
[patent_app_type] => utility
[patent_app_number] => 17/299198
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14420
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299198
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299198 | PROCESS FOR PREPARING A SURFACE WITH BACTERIOSTATIC ACTIVITY AND SURFACE THUS PREPARED | Dec 3, 2019 | Pending |
Array
(
[id] => 18716836
[patent_doc_number] => 11794161
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-10-24
[patent_title] => Reduced permeability microcapsules
[patent_app_type] => utility
[patent_app_number] => 16/682862
[patent_app_country] => US
[patent_app_date] => 2019-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 17
[patent_no_of_words] => 20071
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16682862
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/682862 | Reduced permeability microcapsules | Nov 12, 2019 | Issued |
Array
(
[id] => 16221159
[patent_doc_number] => 20200246275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => COMBINATION THERAPY COMPRISING NANOPARTICLES OF A TAXANE AND ALBUMIN WITH ABT-263 IN METHODS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/678980
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16678980
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/678980 | COMBINATION THERAPY COMPRISING NANOPARTICLES OF A TAXANE AND ALBUMIN WITH ABT-263 IN METHODS FOR TREATING CANCER | Nov 7, 2019 | Abandoned |
Array
(
[id] => 15927617
[patent_doc_number] => 20200155442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => SKIN LIGHTENING COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/662917
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16662917
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/662917 | SKIN LIGHTENING COMPOSITIONS | Oct 23, 2019 | Abandoned |